LloydsPharmacy Clinical Homecare has officially rebranded to Lloyds Clinical, marking a transformative milestone in its evolution as a leader in specialist clinical treatments delivered outside the hospital.
This rebrand signifies Lloyds Clinical’s evolution as an independent, innovative provider of high-quality care delivered in the community – including patients’ homes and dedicated clinics. With over 30 years of expertise, Lloyds Clinical combines leading-edge treatment protocols, exceptional patient care, and trusted partnerships to deliver improved outcomes for patients and healthcare systems across the UK. With the company’s significant investment in state-of-the-art technology, both patients and customers will experience a level of professionalism and expertise beyond their expectations.
A Trusted Partner in Healthcare
Lloyds Clinical’s resilience and ability to adapt in an ever-changing healthcare landscape have been key to its success. Supporting almost 100,000 patients, the organisation has solidified its position as a trusted partner for NHS trusts, healthcare professionals, and patients alike.
To accelerate its growth, private equity investor AURELIUS is providing a multi-million-pound investment. This funding will enable the digitisation of services, the expansion of clinical offerings, the establishment of the Lloyds Clinical Oncology Academy, and foster further innovation – ensuring Lloyds Clinical remains a leader in delivering patient-centred healthcare solutions.
Reducing NHS Pressures Through Specialist Clinics
Lloyds Clinical’s vision is to be the first choice for patients and healthcare professionals outside the hospital, with an ambition to create a world where patients don’t wait for treatment. As part of their commitment to supporting the NHS, Lloyds Clinical is focused on alleviating pressures on hospital resources by providing specialist clinical treatments within the community.
A key element of this support is their specialist community clinics. These clinics:
- Expand treatment capacity by up to 30%, reducing strain on hospitals.
- Support NHS cancer recovery targets, ensuring patients receive timely care.
By ensuring patients receive the right care, at the right time, in the right place, these clinics provide significant benefits for both patients and healthcare providers, exemplifying Lloyds Clinical’s commitment to advancing and improving treatment outcomes.
Paul Adams, CEO of Lloyds Clinical, said:
“The rebrand to Lloyds Clinical is more than just a name change – it’s a bold step forward that emphasises our firm commitment to transforming healthcare. We remain steadfast in our mission to provide exceptional care in the community, which includes the homes of patients, as well as our clinics, thus ensuring patients receive the treatment they need, when and where they need it.
“In a time of significant challenges and changes within the healthcare landscape, our core identity and mission have never wavered. Lloyds Clinical has built a strong foundation of trust and resilience, underpinned by recent strategic investments in technology, staff development, and service expansion. These efforts ensure we can meet the evolving needs of our patients and partners while remaining a trusted provider in the homecare medicines services market.
“Our specialist community clinics are a prime example of how we are helping to address NHS capacity challenges, reducing hospital pressures, and improving faster access to care. With over 30 years of experience, strong financial growth, and an ongoing multi-million-pound investment provided by AURELIUS, Lloyds Clinical’s not only pioneering the way for more advanced clinical treatments for chronic decreases to be undertaken in the community, but also helping the NHS to reduce its backlogs. Together, we are building the public’s confidence in a healthcare system that continues to evolve for the better.”
A Vision for the Future
Lloyds Clinical’s rebrand reflects its mission to ensure patients never wait longer than necessary for treatment, while supporting healthcare professionals in advancing specialist therapies. Its forward-looking strategy includes:
- Expanding clinical services to meet the growing demand for chronic disease treatments, with a strong focus on oncology.
- Leveraging digital tools to streamline operational capabilities and reduce the time from diagnosis to treatment.
- Collaborating with healthcare specialists on innovative therapies, including biologics and patient-specific treatments.
- Strengthening partnerships with NHS trusts and pharmaceutical companies to become the ‘go-to’ provider for specialist treatments delivered outside the hospital.
For more information about Lloyds Clinical and its services, visit www.lloydsclinical.com.
Image depicts Lloyds Clinical logo